Cargando…

Low Circulating Monocytes Is in Parallel With Lymphopenia Which Predicts Poor Outcome in Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis-Associated Interstitial Lung Disease

Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis (DM)-associated interstitial lung disease (ILD) may progress rapidly and lead to high mortality within 6 or 12 months. Except for reported prognostic factors, simple but powerful prognostic biomarkers are still...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Xia, Jin, Yuyang, Zhang, Danting, Li, Yixuan, Fu, Yakai, Wang, Suli, Ye, Yan, Wu, Wanlong, Ye, Shuang, Yan, Bing, Chen, Xiaoxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802832/
https://www.ncbi.nlm.nih.gov/pubmed/35111785
http://dx.doi.org/10.3389/fmed.2021.808875
_version_ 1784642754826993664
author Lv, Xia
Jin, Yuyang
Zhang, Danting
Li, Yixuan
Fu, Yakai
Wang, Suli
Ye, Yan
Wu, Wanlong
Ye, Shuang
Yan, Bing
Chen, Xiaoxiang
author_facet Lv, Xia
Jin, Yuyang
Zhang, Danting
Li, Yixuan
Fu, Yakai
Wang, Suli
Ye, Yan
Wu, Wanlong
Ye, Shuang
Yan, Bing
Chen, Xiaoxiang
author_sort Lv, Xia
collection PubMed
description Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis (DM)-associated interstitial lung disease (ILD) may progress rapidly and lead to high mortality within 6 or 12 months. Except for reported prognostic factors, simple but powerful prognostic biomarkers are still in need in practice. In this study, we focused on circulating monocyte and lymphocyte counts and their variation tendency in the early stage of ILD. A total of 351 patients from two inception anti-MDA5 antibody-positive cohorts were included in this study, with various treatment choices. Lymphocyte count remained lower in the first month after admission in the non-survivor patients. Although baseline monocyte count showed no significant differences, average monocyte count in the following 4 weeks was also lower in the non-survivor group. Based on the C-index and analysis by the “survminer” R package in the discovery cohort, we chose 0.24 × 109/L as the cutoff value for Mono W0-2, 0.61 × 109/L as the cutoff value for lymph W0-2, and 0.78 × 109/L as the cutoff value for peripheral blood mononuclear cell (PBMC) W0-2, to predict the 6-month all-cause mortality. The Kaplan–Meier survival curves and adjusted hazard ratio with age, gender, and the number of immunosuppressants used all validated that patients with lower average monocyte count, lower average lymphocyte count, or lower average PBMC count in the first 2 weeks after admission had higher 6-month death risk, no matter in the validation cohort or in the pooled data. Furthermore, flow cytometry figured out that non-classical monocytes in patients with anti-MDA5 antibody-positive DM were significantly lower than healthy controls and patients with DM without anti-MDA5 antibodies. In conclusion, this study elucidated the predictive value of monocyte and lymphocyte counts in the early stage and may help rheumatologists to understand the possible pathogenesis of this challenging disease.
format Online
Article
Text
id pubmed-8802832
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88028322022-02-01 Low Circulating Monocytes Is in Parallel With Lymphopenia Which Predicts Poor Outcome in Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis-Associated Interstitial Lung Disease Lv, Xia Jin, Yuyang Zhang, Danting Li, Yixuan Fu, Yakai Wang, Suli Ye, Yan Wu, Wanlong Ye, Shuang Yan, Bing Chen, Xiaoxiang Front Med (Lausanne) Medicine Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis (DM)-associated interstitial lung disease (ILD) may progress rapidly and lead to high mortality within 6 or 12 months. Except for reported prognostic factors, simple but powerful prognostic biomarkers are still in need in practice. In this study, we focused on circulating monocyte and lymphocyte counts and their variation tendency in the early stage of ILD. A total of 351 patients from two inception anti-MDA5 antibody-positive cohorts were included in this study, with various treatment choices. Lymphocyte count remained lower in the first month after admission in the non-survivor patients. Although baseline monocyte count showed no significant differences, average monocyte count in the following 4 weeks was also lower in the non-survivor group. Based on the C-index and analysis by the “survminer” R package in the discovery cohort, we chose 0.24 × 109/L as the cutoff value for Mono W0-2, 0.61 × 109/L as the cutoff value for lymph W0-2, and 0.78 × 109/L as the cutoff value for peripheral blood mononuclear cell (PBMC) W0-2, to predict the 6-month all-cause mortality. The Kaplan–Meier survival curves and adjusted hazard ratio with age, gender, and the number of immunosuppressants used all validated that patients with lower average monocyte count, lower average lymphocyte count, or lower average PBMC count in the first 2 weeks after admission had higher 6-month death risk, no matter in the validation cohort or in the pooled data. Furthermore, flow cytometry figured out that non-classical monocytes in patients with anti-MDA5 antibody-positive DM were significantly lower than healthy controls and patients with DM without anti-MDA5 antibodies. In conclusion, this study elucidated the predictive value of monocyte and lymphocyte counts in the early stage and may help rheumatologists to understand the possible pathogenesis of this challenging disease. Frontiers Media S.A. 2022-01-17 /pmc/articles/PMC8802832/ /pubmed/35111785 http://dx.doi.org/10.3389/fmed.2021.808875 Text en Copyright © 2022 Lv, Jin, Zhang, Li, Fu, Wang, Ye, Wu, Ye, Yan and Chen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Lv, Xia
Jin, Yuyang
Zhang, Danting
Li, Yixuan
Fu, Yakai
Wang, Suli
Ye, Yan
Wu, Wanlong
Ye, Shuang
Yan, Bing
Chen, Xiaoxiang
Low Circulating Monocytes Is in Parallel With Lymphopenia Which Predicts Poor Outcome in Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis-Associated Interstitial Lung Disease
title Low Circulating Monocytes Is in Parallel With Lymphopenia Which Predicts Poor Outcome in Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis-Associated Interstitial Lung Disease
title_full Low Circulating Monocytes Is in Parallel With Lymphopenia Which Predicts Poor Outcome in Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis-Associated Interstitial Lung Disease
title_fullStr Low Circulating Monocytes Is in Parallel With Lymphopenia Which Predicts Poor Outcome in Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis-Associated Interstitial Lung Disease
title_full_unstemmed Low Circulating Monocytes Is in Parallel With Lymphopenia Which Predicts Poor Outcome in Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis-Associated Interstitial Lung Disease
title_short Low Circulating Monocytes Is in Parallel With Lymphopenia Which Predicts Poor Outcome in Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis-Associated Interstitial Lung Disease
title_sort low circulating monocytes is in parallel with lymphopenia which predicts poor outcome in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis-associated interstitial lung disease
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802832/
https://www.ncbi.nlm.nih.gov/pubmed/35111785
http://dx.doi.org/10.3389/fmed.2021.808875
work_keys_str_mv AT lvxia lowcirculatingmonocytesisinparallelwithlymphopeniawhichpredictspooroutcomeinantimelanomadifferentiationassociatedgene5antibodypositivedermatomyositisassociatedinterstitiallungdisease
AT jinyuyang lowcirculatingmonocytesisinparallelwithlymphopeniawhichpredictspooroutcomeinantimelanomadifferentiationassociatedgene5antibodypositivedermatomyositisassociatedinterstitiallungdisease
AT zhangdanting lowcirculatingmonocytesisinparallelwithlymphopeniawhichpredictspooroutcomeinantimelanomadifferentiationassociatedgene5antibodypositivedermatomyositisassociatedinterstitiallungdisease
AT liyixuan lowcirculatingmonocytesisinparallelwithlymphopeniawhichpredictspooroutcomeinantimelanomadifferentiationassociatedgene5antibodypositivedermatomyositisassociatedinterstitiallungdisease
AT fuyakai lowcirculatingmonocytesisinparallelwithlymphopeniawhichpredictspooroutcomeinantimelanomadifferentiationassociatedgene5antibodypositivedermatomyositisassociatedinterstitiallungdisease
AT wangsuli lowcirculatingmonocytesisinparallelwithlymphopeniawhichpredictspooroutcomeinantimelanomadifferentiationassociatedgene5antibodypositivedermatomyositisassociatedinterstitiallungdisease
AT yeyan lowcirculatingmonocytesisinparallelwithlymphopeniawhichpredictspooroutcomeinantimelanomadifferentiationassociatedgene5antibodypositivedermatomyositisassociatedinterstitiallungdisease
AT wuwanlong lowcirculatingmonocytesisinparallelwithlymphopeniawhichpredictspooroutcomeinantimelanomadifferentiationassociatedgene5antibodypositivedermatomyositisassociatedinterstitiallungdisease
AT yeshuang lowcirculatingmonocytesisinparallelwithlymphopeniawhichpredictspooroutcomeinantimelanomadifferentiationassociatedgene5antibodypositivedermatomyositisassociatedinterstitiallungdisease
AT yanbing lowcirculatingmonocytesisinparallelwithlymphopeniawhichpredictspooroutcomeinantimelanomadifferentiationassociatedgene5antibodypositivedermatomyositisassociatedinterstitiallungdisease
AT chenxiaoxiang lowcirculatingmonocytesisinparallelwithlymphopeniawhichpredictspooroutcomeinantimelanomadifferentiationassociatedgene5antibodypositivedermatomyositisassociatedinterstitiallungdisease